市场调查报告书
商品编码
1479957
全球心臟瓣膜产业,预测到2028年Global Heart Valves Industry Forecast to 2028 |
投资创新技术创造成长机会
在本次分析中,Frost & Sullivan 涵盖了心臟瓣膜产业,包括主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣。它解决了市场规模、成长率、成长机会、策略要务、技术影响和行业开拓潜力等关键问题。
根据分析,由于经导管技术的日益采用,该行业正在获得关注。经导管主动脉瓣置换术(TAVR)在过去几年中取得了良好的成长,并且在预测期内可能会继续成长。
产业相关人员正在开发经导管二尖瓣和三尖瓣技术,以抓住下一阶段的成长机会。 Frost & Sullivan 认为,随着许多新技术的发展以及这些技术的临床证据和监管核准的增加,心臟瓣膜产业正处于曲折点。
目标区域为北美、欧洲、亚太地区、拉丁美洲和中东/非洲。由于存在许多大公司和新兴企业,北美是最大的市场。由于受瓣膜性心臟病影响的人数众多以及人们对瓣膜性心臟病技术的认识和可及性不断提高,该行业在亚太地区正在快速增长。
研究期间为2021-2028年,其中2023年为基准年,2024-2028年为预测期间。
Investments in Innovative Technologies Enable Growth Opportunities
In this analysis, Frost & Sullivan covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. We address critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry.
Our analysis shows that the industry is gaining traction due to the increasing adoption of transcatheter technologies. Transcatheter aortic valve replacement (TAVR) procedures recorded lucrative growth in the past few years and will continue to grow in the forecast period.
Industry participants are developing transcatheter mitral and tricuspid valve technologies to capture the next growth phase. Frost & Sullivan finds that the heart valves industry has reached an inflection point due to the development of many new technologies as well as the rise in clinical evidence and regulatory approval for these technologies.
Regional coverage includes North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa. North America is the largest market due to the presence of many large companies and emerging companies. The industry is growing rapidly in Asia-Pacific because of the high number of people suffering from heart valve diseases and growing awareness and accessibility to heart valve technologies.
The study period is 2021-2028, with 2023 as the base year and 2024-2028 as the forecast period.